The Clinical Encyclopedia of Nutritional Psychiatry
Evidence-Based Herbs, Supplements, and Vitamins for Mental Health
The Paradigm Shift in Nutritional Psychiatry
For most of the last century, the pharmacology of psychiatric illness was tethered to a single idea, the monoamine hypothesis, which held that mood disorders were essentially a shortage of serotonin, norepinephrine, or dopamine at the synapse. Nearly every front-line medication was engineered to nudge those three chemicals. That model produced real relief for many people, but it never explained why so many patients failed to respond, why symptoms so often returned, and why the body, not just the mind, seemed so deeply involved in psychological suffering.
Contemporary psychiatric research has moved well beyond that narrow frame. The pathophysiology of depression, anxiety, and the neurodevelopmental conditions is now understood to involve systemic neuroinflammation, mitochondrial bioenergetics (the brain's literal energy supply), oxidative stress, epigenetic regulation of gene expression, and the bidirectional signaling network known as the microbiota-gut-brain axis. As treatment-resistant depression and chronic anxiety remain stubbornly common and frequently refractory to standard drugs, the careful, targeted use of nutraceuticals, psychobiotics, and plant medicines has moved from the margins of alternative care toward the center of evidence-based adjunctive treatment.
This encyclopedia synthesizes the empirical literature on the herbs, supplements, and vitamins used in mental health and neuropsychiatry. By examining the precise molecular mechanisms, the randomized controlled trials, and the pharmacokinetic profiles that govern how these compounds actually behave inside the body, it offers a working clinical framework rather than a list of folk remedies. Every entry is organized around a simple question: what does this compound physically do to the brain, and what does the strongest available research say about whether it helps.
Advancements in Nutritional Psychology
The treatment of major depressive disorder and bipolar depression increasingly draws on compounds that target three distinct failure points: systemic inflammation, the supply of methyl donors needed to build neurotransmitters, and the stability of mitochondrial energy production. A growing body of clinical data shows that broad-spectrum micronutrition, meaning synergistic combinations of vitamins and chelated minerals rather than a single isolated nutrient, consistently outperforms single-nutrient strategies for conditions like ADHD, major depression, and autonomic nervous system dysregulation. The brain does not run on one ingredient, and it rarely heals on one either.
Bioavailability and the Blood-Brain Barrier
Not all supplements are created equal, and the difference usually comes down to absorption. The blood-brain barrier is an aggressively selective filter designed to protect the brain from the bloodstream, and most cheap, over-the-counter mineral salts such as magnesium oxide are poorly absorbed in the gut and largely fail to cross it at all. Clinical-grade formulations get around this through chelation, which binds a mineral to an organic amino acid so the body treats it as food rather than rock, or through ultra-micronization, which shrinks particle size dramatically (as seen with PEA) to deliver the active compound directly where it is needed. When a study reports that a nutrient does nothing, the form and the dose are often the reason.
Adverse Events and Toxicology
High-potency nutraceuticals and botanicals demand the same scrutiny of drug interactions that any prescription would. The presumption that a natural compound is inherently safe is a dangerous clinical fallacy, one that can lead to life-threatening complications, especially in the setting of psychiatric polypharmacy. Several of the most popular natural agents carry severe contraindications. Always consult your prescribing physician before adding compounds like St. John's Wort or Ashwagandha, which carry significant endocrine and CYP450 risks covered in detail later in this directory.
Sort by Psychiatric Condition
Top Supplements for Anxiety
- L-Theanine, the calming amino acid found in tea
- Magnesium (Bisglycinate), nature's NMDA receptor antagonist
- Ashwagandha, an adaptogen for cortisol regulation
- Inositol (40:1 Ratio), highly effective for panic
- GABA, the primary inhibitory neurotransmitter
- Apigenin, a flavonoid targeting GABA-A receptors
- Chamomile, validated for generalized anxiety
- Lemon Balm & Passionflower, herbal support for nervous tension
- Taurine, a GABAergic, calming amino acid
- CBD, a non-intoxicating endocannabinoid modulator
Top Supplements for Depression
- Omega-3 Fatty Acids (EPA), membrane fluidity and anti-inflammatory
- Vitamin D, a hormone crucial for neurogenesis and mood
- B Vitamins (B6, L-5-MTHF, B12), methylation cycle drivers
- SAMe, the universal methyl donor for monoamine synthesis
- Zinc, an essential mineral linked to BDNF activity
- Saffron, a spice with proven antidepressant properties
- Curcumin, an anti-inflammatory antidepressant
- Creatine, restores bioenergetics in major depression
- CoQ10, protects mitochondria in bipolar depression
- PEA & Betaine, reverse neuroinflammation in resistant cases
Top Supplements for ADHD
- Zinc, essential for dopamine synthesis and regulation
- Iron (Bisglycinate), critical for attention where ferritin is low
- Magnesium L-Threonate, supports calm neural function and plasticity
- L-Theanine & Caffeine, promotes calm, alpha-wave focus
- Saffron, a gentler alternative to stimulants for hyperactivity
- Phosphatidylserine (PS), supports membrane signaling and memory
Top Supplements for Sleep
- Magnesium, relaxes musculature and calms the nervous system
- Apigenin & Chamomile, trigger chloride ion channels for deep sleep
- Valerian Root, a traditional GABAergic sleep botanical
- Melatonin, corrects circadian rhythm and reduces neuroinflammation
- L-Theanine, promotes relaxation without grogginess
- Glycine, an amino acid that improves sleep architecture
Top Supplements for Cognitive Function
- Lion's Mane, promotes Nerve Growth Factor synthesis
- Bacopa Monnieri, a traditional herb for memory consolidation
- Alpha-GPC & Citicoline, potent choline donors for acetylcholine
- Panax Ginseng, supports mental performance and fatigue
- Acetyl-L-Carnitine, supports mitochondrial ATP function
- Vitamin B12, essential for myelin sheath integrity
Top Supplements for Stress & Trauma
- Holy Basil (Tulsi), blunts physiological cortisol reactivity
- Ashwagandha, reduces cortisol from chronic hyperarousal
- Rhodiola Rosea, increases stress resilience and counters burnout
- Magnesium, depleted rapidly by chronic stress
- Psychobiotics, bacterial strains that modulate the HPA axis
Clinical Conditions & Therapeutic Synergy
Explore our interconnected library of in-depth clinical articles on natural, neurobiological approaches to specific mental health conditions.
Psychiatric Conditions
Neurodevelopmental & Behavioral
Hormonal & Somatic Physiology
Latest Clinical Evidence: Micronutrition
Targeted nutritional interventions recognize the crucial role of broad-spectrum nutrients in brain function, often matching or exceeding pharmaceutical outcomes with fewer side effects.
Finding: A randomized controlled trial (N=324) showed broad-spectrum micronutrients were as effective as antidepressants for treating Major Depressive Disorder, with a superior safety profile.
Finding: Analysis of 18 studies found ADHD symptoms reduced by 42% using micronutrients, with effect sizes comparable to stimulant medication.
Finding: Specific probiotic strains reduced anxiety and depression by modulating the gut-brain axis, showing a 38% symptom improvement.
Finding: High-dose EPA supplementation reduced manic and depressive episodes by 58% as an adjunctive treatment for Bipolar Disorder.
Finding: Broad-spectrum supplementation improved behavioral symptoms and reduced sensory sensitivities in children with Autism Spectrum Disorder.
Finding: Vitamin D supplementation at 2000 to 4000 IU daily reduced depression scores by 32%.
Latest Clinical Evidence: Mindfulness & Somatics
Mindfulness and somatic-based interventions now carry extensive validation for structural brain changes and stress reduction, complementing the biochemical strategies in this directory.
Finding: A large RCT (N=2,456) showed Mindfulness-Based Cognitive Therapy reduced depression relapse by 37%, performing as well as maintenance medication.
Finding: Resilience training based on mindfulness reduced PTSD symptoms by 58%, with particular effectiveness for hyperarousal and dissociation.
Finding: Meta-analysis confirmed that meditation practices produce measurable brain changes, including increased cortical thickness, in just 8 weeks.
Finding: Interventions reduced chronic pain intensity by 22% and pain-related disability by 35%, offering an alternative for chronic pain management.
Neuroplasticity Enhancement
Neuroplasticity is the brain's remarkable capacity to reorganize itself by forming new neural connections throughout life. This adaptability allows the brain to compensate for injury, disease, and chronic psychological stress. At Taproot Therapy Collective, we build neuroplasticity principles into our treatment approaches to support healing and change at the biological root rather than only at the level of insight.
The micronutrients catalogued in this directory provide the physical building blocks the brain needs to strengthen the neural pathways associated with stability and adaptive behavior while allowing the pathways linked to distress and dysfunction to weaken. Nutrition does not replace therapy, but it supplies the raw material that makes therapeutic change physically possible.
1. The Depressive Spectrum: Neuroinflammation, Methylation, and Bioenergetics
The treatment of major depressive disorder and bipolar depression increasingly draws on compounds that target three failure points at once: systemic inflammation, the methyl donors needed to build neurotransmitters, and the stability of mitochondrial energy production. The compounds below address the physical machinery of mood rather than serotonin alone.
Omega-3 Polyunsaturated Fatty Acids (EPA & DHA)
Omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are critical structural components of the neuronal cell membrane, where they govern membrane fluidity, receptor affinity, and the neuroinflammatory cascades that increasingly appear central to depression. The clinical effect in depressive disorders is highly dependent on the exact EPA-to-DHA ratio, and the superiority of EPA is driven by its potent anti-inflammatory action, particularly its ability to competitively inhibit the conversion of arachidonic acid into pro-inflammatory prostaglandins and leukotrienes.
Formulation is therefore everything. Extensive meta-analyses indicate that preparations containing at least 60 percent EPA, administered at pharmacological doses above 1 gram per day, yield statistically significant improvements in depressive symptoms, while DHA-pure or DHA-majority formulations routinely fail to show comparable benefit. Pre-treatment biology also predicts response: high baseline erythrocyte levels of EPA and DHA, together with a high ratio of EPA and DHA to arachidonic acid, have been identified as biomarkers for a favorable outcome. Large population data from the National Health and Nutrition Examination Survey reinforce the pattern, with higher omega-3 intake associated with lower depression severity and lower mortality risk, an effect partly mediated by improvements in systemic inflammatory indices.
S-adenosylmethionine (SAMe)
SAMe is a naturally occurring sulfur-containing compound and the principal universal methyl donor in the central nervous system. It sits at the intersection of three central metabolic pathways: trans-sulfuration, which produces the master antioxidant glutathione; transaminopropylation, which builds polyamines; and methylation, which governs the synthesis and breakdown of the monoamine neurotransmitters. Because abnormal levels of folate, homocysteine, and SAMe all correlate with a higher risk of depression, supplying the methyl donor directly can restart a stalled cycle.
Clinical trials of SAMe, typically dosed between 800 and 1600 milligrams daily, have demonstrated antidepressant efficacy superior to placebo, and head-to-head comparisons show it to be non-inferior to the tricyclic imipramine and the SSRI escitalopram. Optimal effect is generally observed with oral or intramuscular administration, whereas intravenous delivery has not produced consistent benefit.
L-Methylfolate (L-5-MTHF)
The methylation cycle is fundamental both to the synthesis of monoamine neurotransmitters and to the epigenetic regulation of gene expression, and dysfunction in this one-carbon pathway is now a recognized driver of treatment-resistant depression. The conversion of dietary folate or synthetic folic acid into its biologically active form depends on the enzyme methylenetetrahydrofolate reductase (MTHFR). Common genetic polymorphisms in the MTHFR gene, specifically the 677C to T and 1298A to C variants, reduce enzymatic activity, elevate homocysteine, and significantly raise the risk of depression. This bottleneck is often compounded by vitamin B12 deficiency, which can sequester folate in an inactive form and produce a functional shortage despite normal serum readings.
Because L-methylfolate is the only form of folate that readily crosses the blood-brain barrier, it bypasses the enzymatic bottleneck entirely and acts as a critical adjunct. Supplementation at pharmacological doses of 7.5 to 15 milligrams daily has been shown to rapidly augment SSRI and SNRI response. In naturalistic studies, patients given adjunctive L-methylfolate achieved a 58.2 percent decrease in PHQ-9 depression scores, with high response (67.9 percent) and remission (45.7 percent) rates in treatment-resistant populations, and without the metabolic side effects typical of atypical antipsychotic augmentation. A documented case of a woman with a twenty-year history of treatment-resistant depression who achieved remission after a slow titration to 15 milligrams daily illustrates the precision-medicine potential of MTHFR-guided dosing.
Creatine Monohydrate
Impaired brain bioenergetics, marked by altered turnover of adenosine triphosphate and mitochondrial dysfunction, are increasingly implicated in the biology of mood disorders. Long viewed only as an ergogenic aid for athletes, creatine functions systemically as a bioenergetic molecule, regenerating intracellular high-energy phosphates by converting adenosine diphosphate back into ATP through the enzyme creatine kinase. In the brain, this buffering capacity translates into measurable cognitive and emotional benefit.
In patients with major depression, adding 2 to 10 grams per day of creatine to standard escitalopram therapy produced a significantly accelerated and augmented antidepressant response, with effects appearing as early as the second week of treatment. The data also point to a sexually dimorphic pattern, with women showing more pronounced benefit, likely reflecting baseline differences in brain creatine kinase expression and the supportive effect of estrogen on mitochondrial capacity. In older adults and those with mild cognitive impairment, high-dose administration of 10 to 20 grams per day safely raises brain creatine concentration and improves attention, memory, and processing speed, with a weight-based strategy of roughly 0.10 to 0.14 grams per kilogram per day proposed as an optimal personalized approach.
Coenzyme Q10 (CoQ10)
Working within the phospholipid bilayers of the mitochondria, CoQ10 serves a dual role as an essential electron shuttle for ATP generation in the electron transport chain and as a potent antioxidant. Bipolar disorder in particular shows a phasic dysregulation of mitochondrial bioenergetics, with increased energy demand during mania and a steep decline in energy production during depression, which is precisely the kind of imbalance CoQ10 is positioned to correct. Plasma levels plateau at oral intakes around 2400 milligrams per day, which establishes a practical therapeutic ceiling.
In double-blind, placebo-controlled trials of geriatric and adult bipolar depression, adjunctive CoQ10 at titrated doses of 200 to 1200 milligrams per day significantly reduced depressive symptoms over an eight-week period by reversing energetic dyshomeostasis and counteracting the oxidative stress and neuroinflammation inherent to the bipolar state. Combined protocols pairing CoQ10 with creatine have demonstrated synergistic neuroprotection in Parkinson's disease outpatients, diminishing phospholipid markers of oxidative stress while enhancing cognition.
Saffron (Crocus sativus)
Saffron has emerged as a premier botanical intervention for depression, anxiety, and cognitive decline. Its primary bioactive constituents, crocin, crocetin, and safranal, exert broad neuroprotective and antidepressant effects by inhibiting the synaptic reuptake of serotonin, dopamine, and norepinephrine, modulating NMDA and GABA receptors, and acting as potent systemic antioxidants. It also enhances cognition through acetylcholinesterase inhibition, raising synaptic acetylcholine in a manner similar to pharmaceutical cholinesterase inhibitors, and it dampens neuroinflammation by inhibiting nuclear factor-kappa B, suppressing the NLRP3 inflammasome, and activating the Nrf2 antioxidant pathway.
For unipolar depression, umbrella meta-analyses show that saffron standardized to 30 milligrams per day produces a large effect size and proves statistically non-inferior to fluoxetine, citalopram, and imipramine, with a far gentler side-effect profile. It has also demonstrated safety and benefit as an adjunct in attention-deficit hyperactivity disorder, where it acts as a mild natural stimulant that enhances dopamine transmission. The breadth of its randomized evidence is summarized below.
| Trial | Population | Dosage & Duration | Primary Finding |
|---|---|---|---|
| Akhondzadeh et al. (2005) | Outpatients with MDD | 30 mg/day vs. 20 mg/day fluoxetine, 6 weeks | Comparable, significant improvement. Mean HAM-D reduction of 12.0 for saffron versus 11.0 for fluoxetine. |
| Moshiri et al. (2006) | Mild-to-moderate depression | 30 mg/day saffron vs. placebo, 6 weeks | Saffron significantly superior to placebo in reducing HAM-D scores (p less than 0.001). |
| Talaei et al. (2015) | MDD patients on SSRI therapy | 15 mg crocin twice daily as adjunct vs. placebo, 4 weeks | Crocin group showed significantly greater improvement on the Beck Depression Inventory, indicating additive effects. |
| Akhondzadeh et al. (2010) | Mild-to-moderate Alzheimer's | 30 mg/day vs. 10 mg/day donepezil, 22 weeks | Comparable cognitive efficacy to donepezil with fewer adverse events. |
| Farokhnia et al. (2014) | Moderate-to-severe Alzheimer's | 30 mg/day vs. 20 mg/day memantine, 52 weeks | No significant difference in efficacy and equal tolerability over a full year. |
Curcumin (Turmeric)
Curcumin, the principal polyphenol in turmeric, has become one of the most studied natural antidepressants precisely because depression is increasingly understood as an inflammatory condition. It acts as a broad anti-inflammatory and antioxidant agent, inhibiting nuclear factor-kappa B and the pro-inflammatory cytokines that disrupt monoamine signaling, while raising levels of brain-derived neurotrophic factor, the growth factor that supports the survival and plasticity of neurons. It also gently modulates serotonin and dopamine and dampens the hyperactive stress response of the hypothalamic-pituitary-adrenal axis.
Randomized controlled trials and meta-analyses indicate that curcumin produces a significant reduction in depressive symptoms compared with placebo, with the strongest effects in middle-aged patients and in atypical, inflammation-linked depression, and several trials show benefit as an adjunct to standard antidepressants. The central practical problem is bioavailability, since curcumin on its own is poorly absorbed and rapidly metabolized. Formulations that pair it with piperine from black pepper, or that use phytosomal, micellar, or nanoparticle delivery systems, raise absorption by an order of magnitude and are the forms used in the positive clinical literature.
Palmitoylethanolamide (PEA)
The role of glial cell activation, a leaky blood-brain barrier, and the over-secretion of inflammatory cytokines in psychiatric illness has driven interest in lipid signaling molecules the body already makes. PEA is one such endogenous lipid mediator, exerting neuroprotective, analgesic, and anti-inflammatory effects primarily by activating the peroxisome proliferator-activated receptor alpha, engaging the GPR55 and GPR119 receptors, and stabilizing mast cells so they release fewer inflammatory signals.
As an adjunct to standard SSRI therapy, PEA at 600 milligrams twice daily significantly accelerates and enhances the antidepressant response. Human trials also show that the standardized 600 milligram per day formulation improves heart rate variability, a marker of autonomic resilience to stress, and that in people at clinical high risk for psychosis it reduces uncharacteristic thought content and improves social functioning while modifying inflammatory biomarkers. The ultramicronized form, which uses a reduced particle size to achieve far better penetration of the blood-brain barrier, has proven especially effective in reversing post-viral depression and chronic fatigue by directly addressing the underlying neuroinflammation.
Trimethylglycine (Betaine)
Betaine works simultaneously as a systemic osmotic regulator and as a critical methyl donor, and recent psychopharmacological research has identified a third role that may matter most for mood: it is a potent downregulator of the NLRP3 inflammasome, a multiprotein complex tightly linked to severe stress and neuroinflammation. By suppressing NLRP3 activation, betaine pushes microglia, the brain's resident immune cells, away from the pro-inflammatory M1 phenotype that secretes toxic TNF-alpha and IL-1beta and toward the neuroprotective, reparative M2 phenotype.
In animal models, this exact mechanism significantly attenuates the depression-like behavior and cognitive impairment produced by severe systemic stress, methamphetamine exposure, and colitis-driven inflammation. By also inhibiting the cGAS-STING signaling pathway, betaine supports the repair of hippocampal neurogenesis, the birth of new neurons in the brain region most associated with mood and memory. Its dual identity as a methyl donor means it additionally relieves pressure on the SAMe and homocysteine cycle that sits at the heart of methylation-related depression.
2. Anxiolytics, Stress Adaptogens, and Sleep Architecture
Managing the physical side of generalized anxiety, panic, and chronic stress means downregulating the hypothalamic-pituitary-adrenal axis, calming cortisol reactivity, and strengthening the inhibitory GABAergic tone that allows the nervous system to stand down.
Inositol Stereoisomers
Myo-inositol, a natural isomer of glucose, is a critical precursor to the intracellular phosphatidyl-inositol second-messenger system, a pathway used heavily by serotonergic, dopaminergic, and glutamatergic receptors. By restoring the downstream signaling these receptors depend on, high-dose inositol can ease anxiety through the same systems that medications target, but from a different direction.
For panic and obsessive-compulsive disorder, high-dose myo-inositol at 12 to 18 grams per day has shown substantial benefit, significantly reducing the frequency and severity of panic attacks with efficacy comparable to the SSRI fluvoxamine, and double-blind crossover trials confirm its effect on OCD symptom scores. Unlike SSRIs, it is largely free of nausea and fatigue. Inositol is also central to polycystic ovary syndrome, a condition highly comorbid with anxiety and depression, where the body uses two stereoisomers, myo-inositol and D-chiro-inositol, to mediate insulin signaling. A physiological ratio of roughly 40 to 1 of myo-inositol to D-chiro-inositol best restores insulin sensitivity, lowers androgen synthesis, and improves ovulatory function, while D-chiro-inositol alone or in skewed ratios can act as an aromatase inhibitor and paradoxically worsen ovarian function.
Magnesium Pharmacokinetics
Magnesium is an obligatory intracellular cofactor for more than 300 enzymatic reactions, and central nervous system depletion correlates strongly with depression, severe anxiety, migraine, and disrupted sleep. The clinical effect of magnesium is dictated almost entirely by its chelated form, because the blood-brain barrier is highly restrictive to inorganic magnesium salts. Choosing the right compound is the difference between a calming nutrient and an expensive laxative.
| Magnesium Formulation | Bioavailability & Target Utility | Neurological & Physiological Efficacy |
|---|---|---|
| Magnesium L-Threonate | Highest blood-brain barrier penetration. Targets cognition, sleep architecture, and memory. | Excellent. Upregulates synaptic plasticity, improves deep sleep and executive function, and can reverse biochemical alterations in nerve cells. |
| Magnesium Bisglycinate | High absorption. Targets anxiety, stress, and muscle relaxation. | High. Calming effects through glycine synergy with very low gastrointestinal upset. Modulates anxious exploratory behavior in models. |
| Magnesium Malate | High absorption. Targets fatigue and neuromuscular performance. | Moderate. Chelated with malic acid to feed the Krebs cycle and maintain prolonged serum elevation. |
| Magnesium Citrate | Moderate-to-high absorption. Used for general repletion. | Low-to-moderate. Mild laxative effect and poor targeted CNS elevation compared with threonate, though it may selectively raise hippocampal BDNF. |
| Magnesium Oxide/Sulfate | Extremely poor absorption, under 10 percent. Insoluble in water. | Minimal. Remains largely in the intestinal tract and causes osmotic diarrhea. Lowest bioavailability of all preparations. |
Systematic reviews confirm that bioavailable magnesium significantly improves depression and anxiety scores, particularly over a four-week course and when combined with synergistic cofactors such as vitamin B6 or vitamin D, the latter showing notable benefit for emotional regulation in children with ADHD.
Apigenin and Flavonoid Sedatives
Apigenin, a bioflavonoid found abundantly in chamomile, celery, and citrus peel, carries profound sedative, anxiolytic, and neuroprotective properties. It works through positive allosteric modulation of GABA-A receptors and activation of chloride ion channels, the same inhibitory machinery that benzodiazepines exploit, producing deep and restorative sleep without the same dependence profile.
Beyond sedation, apigenin has been identified as a potent inhibitor of the NADase enzyme CD38, a glycoprotein that consumes the vital metabolic coenzyme NAD+. By inhibiting CD38, apigenin restores systemic NAD+ levels, conferring anti-aging, metabolic, and neuroprotective benefits across neurodegenerative models, reducing markers of oxidative stress and raising the activity of endogenous antioxidants such as superoxide dismutase and catalase. Its sleep effect is also strongly synergistic with magnesium: in controlled animal models the combination extended sleep duration by 44 percent under normal conditions and reversed caffeine-induced insomnia, outperforming either compound alone.
Rhodiola rosea
Standardized to the bioactive compounds salidroside and rosavin, Rhodiola is an adaptogen that reduces burnout, mental fatigue, and stress-induced depression by normalizing the body's response to stress rather than sedating it. It is one of the better-studied botanicals for the specific syndrome of being depleted rather than acutely anxious.
Holy Basil (Ocimum tenuiflorum / Tulsi)
Holy basil extracts, particularly standardized formulations such as Holixer, act on the neuroendocrine stress nodes by inhibiting corticotropin-releasing hormone receptor 1 and suppressing 11-beta-hydroxysteroid dehydrogenase-1, two control points that govern how strongly the body mounts a cortisol response. The result is a measurable blunting of physiological stress reactivity rather than a purely subjective sense of calm.
In eight-week randomized trials using 250 milligrams per day, holy basil produced significant reductions in hair cortisol, salivary amylase, and the acute systolic blood pressure spike triggered by a standardized laboratory stressor, and participants reported a 48 percent reduction in insomnia severity. The combination of objective and subjective improvement makes it a strong choice for stress that has begun to fragment sleep.
Lemon Balm & Passionflower
Passionflower (Passiflora incarnata) and lemon balm (Melissa officinalis) are well-tolerated botanicals that reliably reduce anxiety and psychological distress while remaining gentle enough for daytime use. Lemon balm contains an array of phytochemicals, including rosmarinic acid, which modulates the cholinergic and GABAergic pathways. Clinical meta-analyses report that it significantly improves anxiety and depression scores, with a standardized mean difference for anxiety near 0.98, while improving working memory and easing physiological arousal without daytime drowsiness.
Passionflower, for its part, has shown anxiolytic effects comparable in some studies to the benzodiazepines oxazepam and mexazolam, but without the memory impairment and decline in psychomotor function those drugs produce. Together the two herbs offer a layered approach to nervous tension that supports rather than suppresses cognition.
Chamomile (Matricaria recutita)
Chamomile is the whole-plant source from which much of apigenin's sedative reputation derives, and as a standardized extract it has its own respectable clinical record for generalized anxiety disorder. Its anxiolytic action comes from a blend of flavonoids, chiefly apigenin, that bind GABA-A receptors and gently modulate the monoamine and HPA axis systems, producing calm without the cognitive blunting of stronger sedatives.
In randomized controlled trials, standardized chamomile extract dosed at roughly 500 to 1500 milligrams per day produced clinically meaningful reductions in generalized anxiety symptoms, and longer-term data suggest it can lower the rate of symptom relapse while modestly improving depressive symptoms that travel alongside chronic anxiety. As a tea it is mild, while standardized capsules deliver the consistent dose used in the trials, making it a reasonable first step for people who want a gentle, well-tolerated option.
Valerian Root (Valeriana officinalis)
Valerian is one of the oldest botanical sleep aids in continuous clinical use, and its mechanism is now reasonably well mapped. Its constituents, including valerenic acid, increase available GABA and modulate GABA-A receptors, while also interacting with adenosine and serotonin systems involved in the transition into sleep. The effect is a reduction in the time it takes to fall asleep and an improvement in subjective sleep quality, typically without the next-morning grogginess associated with sedative hypnotics.
The clinical evidence is genuinely mixed, with some trials showing clear benefit for sleep latency and quality and others showing little separation from placebo, which likely reflects wide variation in extract potency and the slow, cumulative way the herb tends to work over a couple of weeks rather than on the first night. It is generally well tolerated, though it should not be combined casually with alcohol, benzodiazepines, or other sedatives, since the GABAergic effects can stack.
Cannabidiol (CBD)
CBD has drawn considerable attention for its relatively rapid anxiolytic effect. By interacting with the body's endocannabinoid system, it helps regulate mood, appetite, and sleep, and observational and clinical data indicate that a large share of users, in some samples up to 79 percent, report decreased anxiety within the first month of use. Unlike THC, it is non-intoxicating, which makes it usable during the day for many people.
Melatonin: Neuroprotection & Microglial Polarization
Although it is best known for regulating circadian rhythm and the sleep-wake cycle, melatonin has emerged as a surprisingly potent therapeutic agent for neurodegenerative disease and traumatic brain injury. It acts as a direct scavenger of free radicals and as an anti-inflammatory agent that prevents the energy depletion that follows brain trauma. Standard sleep protocols use 2 to 3 milligrams taken one to two hours before bed for four to twelve weeks, and it is clinically useful for sleep disturbance across diverse populations, including people with schizophrenia, autism, and Parkinson's disease.
3. Neuromodulators for ADHD, ASD, and Cognitive Enhancement
The therapeutic landscape for neurodevelopmental conditions and age-related cognitive decline has expanded to include precise microbiome modulators, choline donors, and nootropic plant extracts that support attention, memory, and the growth factors behind neuroplasticity.
Psychobiotics: The Microbiota-Gut-Brain Axis
The gut microbiome shapes central nervous system function through the vagus nerve, the production of short-chain fatty acids, and the direct synthesis of key neurotransmitters, including as much as 90 percent of the body's serotonin. When the microbial balance is disrupted, neurotoxic lipopolysaccharides leak into the bloodstream and drive the low-grade neuroinflammation that underlies depression, ADHD, and autism. Psychobiotics are live biotherapeutics chosen specifically for their mental health effects, and the two best-characterized profiles are summarized below.
| Psychobiotic Strain Profile | Neurochemical Mechanism | Primary Clinical Applications |
|---|---|---|
| Lactobacillus helveticus R0052 & Bifidobacterium longum R0175 | Decreases pro-inflammatory cytokines, upregulates BDNF in the hippocampus, prevents stress-induced catecholamine spikes, and normalizes the HPA axis. | Major Depressive Disorder and general anxiety. Reduces psychological distress scores by 49 percent, depression scores by 50 percent, and lowers free urinary cortisol by 13 percent. |
| Lactobacillus plantarum PS128 | Increases dopamine and serotonin in the prefrontal cortex and striatum and significantly reduces serum corticosterone and IL-6. | ADHD and Autism Spectrum Disorder. Eases hyperactivity, impulsivity, and oppositional behavior in children and improves attention span. |
Phospholipids and Choline Donors
Phosphatidylserine is a vital structural phospholipid heavily enriched in neuronal tissue, and in children with ADHD, supplementation with 200 milligrams per day of soy- or sunflower-derived material significantly improves short-term auditory memory, reduces inattention, and lowers hyperactive and aggressive behavior, all without the side effects associated with psychostimulants. It supports the physical integrity of the membranes across which neurons signal.
The choline donors Alpha-GPC and citicoline are both used for cognitive decline, but they behave differently. Pharmacokinetic comparisons show that Alpha-GPC produces a faster and higher peak in free plasma choline, and meta-analyses find it statistically superior to citicoline for improving cognitive dysfunction in multi-infarct and adult-onset dementia. Citicoline nonetheless remains highly valuable for stroke recovery and for slowing early dementia, in part through its interaction with SIRT1, which reduces the toxicity of amyloid-beta. The choice between them depends on whether the goal is acute cholinergic support or longer-term neuroprotection.
Bacopa monnieri
Bacopa, known in Ayurvedic medicine as Brahmi, is a premier nootropic that protects cholinergic neurons, reduces stress-induced hippocampal damage, and upregulates the receptor signaling involved in learning. Its active triterpenoid saponins, the bacosides, enhance synaptic plasticity and the slow consolidation of memory rather than producing an acute stimulant effect.
Systematic reviews confirm that Bacopa reliably improves memory free recall and short-term memory, and direct network meta-analyses indicate that high-dose Bacopa at 600 milligrams or more per day outperforms Ginkgo biloba for working memory and processing speed in healthy adults. A double-blind trial in Parkinson's disease found that 225 to 400 milligrams daily for ninety days improved both motor and emotional function, and an ongoing trial is tracking its effect on cognition in early Alzheimer's disease. It carries a high therapeutic index but should be avoided in hyperthyroidism and can cause gastrointestinal upset such as nausea and looser stools.
Lion's Mane (Hericium erinaceus)
This medicinal mushroom contains hericenones and erinacines, bioactive compounds small enough to cross the blood-brain barrier, where they directly stimulate the synthesis of nerve growth factor and brain-derived neurotrophic factor. In effect, Lion's Mane signals the brain to grow and repair, which is why it has attracted attention for both cognition and mood.
Clinical trials show that acute doses of 1.8 grams improve reaction time and response inhibition within an hour, and chronic dosing of 3 grams per day over twelve to sixteen weeks eases mild cognitive impairment while reducing anxiety and depression. It also favorably shifts the abundance of short-chain fatty acid-producing gut bacteria, adding an indirect anti-inflammatory benefit on top of its direct neurotrophic effect.
Synergistic Cognitive Enhancement: L-Theanine and Caffeine
Caffeine is a reliable stimulant, but its usefulness is often capped by anxiety, jitteriness, and vasoconstriction. L-theanine, a non-protein amino acid from tea, softens those somatic side effects while amplifying the cognitive gains, regulating neurotransmitter balance and promoting the alpha-wave activity associated with relaxed, alert focus.
L-Carnosine and Zinc-Carnosine
A dipeptide composed of beta-alanine and L-histidine, L-carnosine acts as a neuroprotectant, antioxidant, and GABA modulator, and it reduces cognitive decline in part by stimulating the clearance of senescent cells through the AKT2 signaling pathway. The evidence in autism is honestly mixed: while animal models suggest it restores social recognition by raising oxytocin in the cerebrospinal fluid, rigorous human meta-analyses have found no statistically significant difference between L-carnosine at 10 to 15 milligrams per kilogram and placebo for the core symptoms of socialization, behavior, and communication, so expectations there should be modest.
Its more robust application is the gut. Chelated as zinc-carnosine, the compound adheres tightly to the stomach and intestinal lining, stabilizing the mucosal barrier, healing gastric ulcers, and protecting the gut against damage from non-steroidal anti-inflammatory drugs and radiation. Because a compromised gut barrier is one of the main drivers of the systemic inflammation that disturbs the gut-brain axis, this protective effect is itself meaningfully neuroprotective.
Zinc
Zinc is the second most abundant trace element in the brain, where it modulates NMDA, AMPA, and GABA receptors and controls the expression of brain-derived neurotrophic factor. Deficiency induces apoptotic neuronal cell death and worsens depressive behavior, and low zinc status is heavily implicated in ADHD, cognitive fog, and treatment-resistant anxiety.
To reach the central nervous system, zinc must be supplied as a highly bioavailable organic chelate such as zinc bisglycinate or picolinate. Inorganic forms like zinc sulfate are poorly absorbed, with bioaccessibility under 2 percent, and are further blocked by the phytates in a typical diet, which is why trials using sulfate forms so often disappoint. Form, once again, determines whether the nutrient ever reaches the brain.
Iron
Low serum ferritin is heavily implicated in ADHD, because iron is an obligatory cofactor for tyrosine hydroxylase, the rate-limiting enzyme in the synthesis of dopamine. When iron stores are depleted, dopamine production falters, and attention and motivation suffer. Supplementation with iron bisglycinate chelate at 30 milligrams per day raises long-term ferritin as effectively as ferrous sulfate while avoiding the severe gastrointestinal inflammation and constipation that sulfate salts so often cause. Iron should be supplemented only where ferritin is genuinely low, since excess iron carries its own oxidative risk.
4. Core Vitamins for Mental Health
Vitamins act as the required cofactors for neurotransmitter synthesis and neuroprotection, and a deficiency in any of them can degrade cognition and mood faster than almost any other variable. They are the spark plugs of brain chemistry.
Vitamin D
Vitamin D behaves more like a hormone than a vitamin, regulating the genes involved in brain development and function, modulating neurotransmitter synthesis, and protecting neurons from oxidative damage. Deficiency is extremely common because of indoor lifestyles, and low levels are consistently linked to depression and to seasonal affective disorder, with supplementation at 2000 to 4000 IU daily shown to reduce depression scores in deficient populations. It is one of the few nutrients worth testing directly before and during supplementation.
Vitamin A
Vitamin A is essential for immune function, cell growth, and brain development, and it plays a specific role in neuroplasticity and the consolidation of memory by supporting neurogenesis, the creation of new brain cells, while protecting existing neurons against oxidative stress. Because it is fat-soluble and can accumulate, it is best obtained at moderate, food-level doses rather than in megadose form.
Vitamin C
Vitamin C is a powerful antioxidant and an obligatory cofactor for the enzymes that synthesize dopamine, norepinephrine, and serotonin, which makes it quietly central to mood rather than merely an immune nutrient. It protects brain cells from oxidative damage and supports the healthy clearance of cortisol after a stress response, helping the nervous system return to baseline.
Vitamin E
Vitamin E is a fat-soluble antioxidant whose main job in the brain is to protect the fragile, lipid-rich membranes of neurons from the chain reaction of oxidative damage known as lipid peroxidation. Since neuronal membranes are where signaling actually happens, preserving their integrity has direct consequences for cognition and resilience to neurodegeneration.
Vitamin K2
Vitamin K2 is best known for directing calcium into bone and away from soft tissue, but that same traffic-control function has real consequences for the brain. By activating the proteins that keep calcium out of arterial walls, K2 supports healthy cerebral blood flow and protects the small-vessel circulation on which cognition depends, and emerging work links adequate K2 status to lower vascular contributions to cognitive decline. It also participates in the synthesis of sphingolipids, fats that are essential components of the myelin and neuronal membranes. It is most useful as a companion to vitamin D and calcium, ensuring the calcium those nutrients mobilize is deposited where it belongs.
Thiamin (Vitamin B1)
Thiamin is crucial for the production of cellular energy in the brain and for the synthesis of several neurotransmitters, largely because it sits at the center of glucose metabolism, the brain's primary fuel pathway. A shortage shows up quickly as fatigue, irritability, and cognitive fog, and severe deficiency produces frank neurological damage, which is why it is a foundational rather than optional nutrient.
Riboflavin (Vitamin B2)
Riboflavin drives energy production and the metabolism of other B vitamins, and it plays a specific role in maintaining the myelin sheaths that insulate nerve cells. It has a well-documented place in migraine prevention, where higher doses reduce attack frequency, a benefit that overlaps meaningfully with the population that struggles with anxiety and mood.
Niacin (Vitamin B3)
Niacin participates in more than 400 enzymatic reactions, and in the brain it supports neurotransmitter function, DNA repair, and overall cellular health, in part through its role as a precursor to the metabolic coenzyme NAD+. Because NAD+ availability declines with age and stress, adequate niacin status underpins the bioenergetic resilience that other interventions in this directory aim to restore.
Vitamin B6 (Pyridoxine)
Vitamin B6 is a crucial cofactor in the synthesis of the major neurotransmitters, including serotonin, dopamine, GABA, and melatonin, which makes it one of the most directly mood-relevant of all the vitamins. It also helps regulate homocysteine, tying it to the same methylation chemistry that governs depression risk, and it pairs synergistically with magnesium for anxiety and with the active folate cycle for mood.
Vitamin B12 (Cobalamin)
Vitamin B12 is essential for nerve health, DNA synthesis, and the formation of red blood cells, and its most consequential role for the brain is in building the myelin that insulates nerve fibers and allows signals to travel cleanly. Deficiency, which is common in older adults and in those on plant-based diets, can masquerade as depression, cognitive decline, or neuropathy, and because it can also trigger a folate trap, it should be assessed alongside folate rather than in isolation.
Biotin (Vitamin B7)
Biotin is involved in the metabolism of fats and carbohydrates, supporting the steady cellular energy production that the brain requires, and it contributes to the formation of the myelin sheath that allows for healthy nerve signaling. While outright deficiency is uncommon, its role in energy metabolism makes it a quiet contributor to the broader micronutrient picture.
Pantothenic Acid (Vitamin B5)
Pantothenic acid is essential for synthesizing coenzyme A, a molecule central to energy production and to the manufacture of both stress hormones and the neurotransmitter acetylcholine. Its involvement in the adrenal stress response makes it particularly relevant to people running on chronic stress, where the demand for stress-hormone synthesis is persistently elevated.
Choline
Often grouped with the B vitamins, choline is the direct precursor to acetylcholine, the neurotransmitter at the heart of memory, mood, and the parasympathetic nervous system that governs rest and recovery. Adequate choline supports the cholinergic signaling that underlies learning and attention, and it works in concert with the phospholipid and choline-donor compounds described in the neuromodulator section.
5. Additional Essential Minerals
Minerals form the structural framework and the electrical signaling system of the brain. Without them, neurotransmitters cannot fire, receptors cannot respond, and the whole system loses its charge.
Calcium
Calcium is the most abundant mineral in the body and is essential for nerve transmission and cellular signaling. Within the brain it governs the release of neurotransmitters and the excitability of neurons, making it a direct participant in how messages pass from cell to cell. Its balance with magnesium is particularly important, since the two minerals act as a kind of accelerator and brake on neuronal firing.
Selenium
Selenium is a trace mineral essential for antioxidant defense, serving as a key component of glutathione peroxidase, one of the brain's major antioxidant enzymes, and it also regulates the metabolism of thyroid hormone. Maintaining an optimal serum range, roughly 82 to 85 micrograms per liter in young adults, is associated with a reduced risk of depressive symptoms. Its effects are markedly dose-dependent and bidirectional, however, so more is not better, and supplementation should stay within a moderate physiological window.
Iodine
Iodine is essential for producing the thyroid hormones that regulate metabolism and brain energy, and because thyroid dysfunction is so closely tied to depression, anxiety, and cognitive fog, iodine status sits upstream of a surprising amount of mood. It works in partnership with selenium in thyroid hormone metabolism, and deficiency or excess can both disturb the delicate hormonal balance that keeps mental energy stable.
Chromium
Chromium plays a role in glucose metabolism and insulin sensitivity, and since the brain depends heavily on a steady supply of glucose, chromium's effect on blood sugar regulation can influence mood, with particular relevance to atypical depression and its characteristic carbohydrate cravings and energy crashes. By smoothing the glucose curve, it helps stabilize the energy swings that destabilize mood.
Molybdenum
Molybdenum is a trace mineral that serves as a cofactor for enzymes involved in detoxification, particularly the metabolism of sulfites, a process with direct consequences for neurotoxicity. Its importance is thrown into relief by genetic deficiencies in molybdenum cofactor synthesis, which produce severe neurological damage and behavioral disturbances that can mimic psychiatric disorders, underscoring a neurodevelopmental role that is easy to overlook.
Boron
Boron is an ultratrace mineral that influences the metabolism of steroid hormones, including estrogen and testosterone, and the handling of calcium, magnesium, and vitamin D, all of which feed indirectly into mood and cognition. Human studies of boron supplementation report improvements in measures of attention, memory, and hand-eye coordination, alongside reductions in inflammatory markers. It is needed only in tiny amounts and is generally obtained from a diet rich in fruits, nuts, and vegetables, but it rounds out the trace-mineral picture that broad-spectrum micronutrition aims to complete.
Lithium Orotate (Low-Dose)
Lithium is best known as a high-dose prescription mood stabilizer, but at the very low doses found in some supplements, delivered as lithium orotate, it is studied as a trace mineral with neuroprotective properties distinct from its pharmaceutical use. At these microdoses it appears to support brain-derived neurotrophic factor, protect neurons against excitotoxicity, and modestly stabilize mood and irritability, and population studies have long noted lower rates of suicide and certain neurological conditions in regions with naturally higher lithium in the drinking water.
Great Salt Lake Minerals
Great Salt Lake mineral complexes provide a natural, balanced spectrum of trace minerals concentrated over thousands of years, supplying magnesium, potassium, sodium, and more than 70 trace elements in the proportions that support the brain's electrical and metabolic balance. Rather than isolating a single mineral, this whole-source approach delivers the cofactor diversity that neurotransmitter metabolism and receptor function quietly depend on.
6. Essential Amino Acids
Amino acids are the building blocks of proteins and the direct precursors to the neurotransmitters that regulate mood, cognition, and behavior. Supplying the right precursor can shift the brain's chemistry from the ground up.
GABA (Gamma-Aminobutyric Acid)
GABA is the primary inhibitory, or calming, neurotransmitter in the central nervous system, responsible for shutting down the excessive neural activity that manifests as racing thoughts and panic. Oral GABA's ability to cross the blood-brain barrier is debated, and part of its calming effect may be mediated through the enteric nervous system of the gut, but many people find it useful for acute situational tension, and it pairs naturally with the GABAergic herbs and the magnesium described elsewhere in this directory.
5-HTP (5-Hydroxytryptophan)
5-HTP is the immediate precursor to serotonin, and unlike tryptophan it readily crosses the blood-brain barrier and converts directly into serotonin to regulate mood and sleep. Because it raises serotonin, it should never be combined with SSRIs, SNRIs, MAOIs, or other serotonergic agents without medical supervision, since the combination risks serotonin toxicity. Used carefully on its own, it can support sleep onset and mood.
L-Tryptophan
L-Tryptophan is an essential amino acid that serves as the upstream precursor to 5-HTP, serotonin, and melatonin. Its effects tend to be more gradual and subtle than direct 5-HTP supplementation because the body regulates each step of the conversion, which also makes it a gentler option for supporting mood and the sleep-wake cycle. The same serotonergic cautions regarding combination with antidepressant medications apply.
L-Tyrosine
L-Tyrosine is the precursor to the catecholamines dopamine, norepinephrine, and epinephrine, the neurotransmitters that drive motivation, executive focus, energy, and the acute stress response. It is most useful under conditions of acute stress or sleep deprivation, when catecholamine demand outstrips supply, and supplementation can help preserve working memory and cognitive flexibility during those depleted states rather than acting as a general daily stimulant.
L-Glutamine
L-Glutamine is the most abundant amino acid in the body and a precursor to both glutamate and GABA, but its most underappreciated role for mental health is in the gut. It is the primary fuel for the cells that line the intestine, and it protects that epithelium against injury, including the hydrogen peroxide-driven damage that erodes the gut barrier. By keeping the intestinal lining intact, L-glutamine helps prevent the leakage of inflammatory signals into the bloodstream that drives gut-brain axis dysfunction, which is why it sits at the foundation of any gut-focused approach to mood.
Glycine
Glycine acts as an inhibitory neurotransmitter in its own right and as a cofactor for numerous biochemical reactions, notably the production of the master antioxidant glutathione. It has gentle calming effects and a well-documented ability to improve sleep quality, in part by lowering core body temperature at sleep onset, and a few grams before bed can deepen sleep architecture without the grogginess of a sedative.
Taurine
Taurine is a sulfur-containing amino acid present in high concentrations in the brain, where it behaves as both a neuromodulator and a neuroprotectant. It supports inhibitory, calming GABAergic and glycinergic tone, which underlies its mild anti-anxiety effect, and it helps regulate the movement of calcium inside neurons, protecting them against the excitotoxic overstimulation that damages brain cells under stress. It also functions as an antioxidant and stabilizes cell membranes, and research links it to the clearance of senescent cells through the AKT2 signaling pathway and to broad anti-inflammatory and metabolic benefits that intersect with mood, aging, and energy. Because it is depleted by stress and is generally very well tolerated, it is a reasonable adjunct for anxious, wired states, and it is the calming counterweight to the caffeine with which it is so often paired.
N-Acetylcysteine (NAC)
NAC is a modified form of the amino acid cysteine that serves as the rate-limiting precursor to glutathione, the body's master antioxidant, allowing it to replenish glutathione stores and quench the oxidative stress implicated across psychiatric illness. Its second and more distinctive action is the modulation of glutamate, the brain's main excitatory neurotransmitter, which it helps restore to balance by regulating the glial transporters that govern glutamate in the synapse.
This glutamatergic effect is the reason NAC has accumulated genuine evidence for compulsive and repetitive conditions, including obsessive-compulsive disorder, trichotillomania, and other behaviors driven by a stuck, looping circuit. By dampening excitotoxicity and rebalancing the excitatory and inhibitory tone of the brain, it addresses a mechanism that conventional serotonergic medications do not directly touch, which makes it a valuable adjunct rather than a replacement.
Acetyl-L-Carnitine (ALCAR)
Acetyl-L-Carnitine readily crosses the blood-brain barrier to support mitochondrial function, shuttling fatty acids into the mitochondria where they are burned for the energy that brain cells consume in large quantities. Beyond its bioenergetic role it exerts neuroprotective effects and supports the cholinergic system involved in memory, and clinical interest has centered on its potential in depression, particularly in older adults and in fatigue-dominant presentations, where restoring cellular energy production appears to lift both mood and mental stamina.
Alpha-Lipoic Acid (ALA)
Alpha-Lipoic Acid is an unusual antioxidant in that it is both water and fat soluble, which allows it to work in every compartment of the cell, including deep within the lipid-rich tissue of the brain. It not only neutralizes free radicals directly but also regenerates other spent antioxidants, including vitamins C and E and glutathione, effectively recharging the body's broader antioxidant network. Its role in mitochondrial energy metabolism and its protective effect on nerve tissue have made it a compound of interest for neuroprotection and for the cognitive complaints that accompany metabolic dysfunction.
7. Additional Medicinal Herbs
A broad catalog of traditional and clinically studied botanicals offering localized neuroprotective, circulatory, and anti-inflammatory effects that complement the targeted compounds above.
Ginkgo Biloba
Ginkgo improves cerebral blood flow and the brain's use of oxygen while delivering potent antioxidant protection, which together support general cognitive function and memory retrieval, particularly in older adults and in vascular forms of cognitive decline. It has also shown specific value in reducing anxiety symptoms. While head-to-head data place it behind Bacopa for working memory, its circulatory action gives it a distinct niche where reduced cerebral perfusion is part of the picture.
Panax Ginseng
Panax ginseng, often called true or Asian ginseng, is an adaptogen whose active ginsenosides support mental performance, energy, and resistance to stress. It appears to work on several fronts at once, modulating the HPA stress axis, supporting cerebral circulation and the use of glucose by the brain, and exerting anti-inflammatory and antioxidant effects on neural tissue. Clinical studies report improvements in working memory, calm alertness, and mental fatigue, and it has drawn particular interest for the cognitive sluggishness that accompanies stress, illness, and aging. Because it is mildly stimulating, it is best taken earlier in the day, and it should be used cautiously alongside stimulant medications or in people with poorly controlled blood pressure.
Lavender (Silexan)
Standardized oral lavender preparations, most notably Silexan, act directly on the limbic system to reduce anxiety, restlessness, and agitation, and the clinical evidence places their anxiolytic effect in the same range as low-dose benzodiazepines but without sedation, dependence, or withdrawal. The active mechanism appears to involve modulation of voltage-gated calcium channels that calm overexcited neurons, and unlike many calming agents it does not blunt cognition, which makes it a practical daytime option for generalized anxiety.
Berberine
Berberine is a plant alkaloid best known for its powerful effects on metabolism, but those same actions ripple directly into mood through the gut-brain and metabolic-mood connections. It improves insulin sensitivity and glucose regulation, reshapes the gut microbiome toward a less inflammatory profile, and activates AMPK, a master switch of cellular energy metabolism, while dampening systemic inflammation. Because metabolic dysfunction, blood-sugar instability, and gut dysbiosis are now recognized contributors to depression and anxiety, berberine offers an indirect but mechanistically coherent route to better mood, with the strongest rationale in people whose psychological symptoms travel alongside metabolic or digestive problems. It can lower blood sugar and interacts with a number of medications through the CYP450 system, so it should be used under medical supervision when other drugs are involved.
Olive Leaf Extract
Olive leaf extract contains oleuropein, a polyphenol with substantial antioxidant and anti-inflammatory properties that help protect the brain against the neuroinflammation increasingly tied to mood and cognitive disorders. By reducing oxidative stress and supporting healthy blood vessels, it contributes to the same anti-inflammatory foundation that underlies much of modern nutritional psychiatry.
Shilajit
Shilajit is a mineral-rich exudate formed over centuries from decomposed plant matter in the Himalayas, and its high fulvic acid content enhances mitochondrial ATP production while ferrying trace minerals directly into cells. Preclinical evidence points to improvements in cellular energy and broad antioxidant activity, and its traditional use for vitality and stamina aligns with a bioenergetic mechanism that overlaps with the fatigue and low drive seen in depression.
Spirulina
Spirulina is a blue-green algae of exceptional nutrient density, rich in protein, carotenoids, and antioxidants, and its anti-inflammatory profile supports global brain health rather than targeting a single pathway. Research indicates that it modulates systemic inflammation, protects against certain environmental toxins, and improves measures of both physical and mental quality of life, making it a useful whole-food foundation within a broader regimen.
Ginger Root Extract
Ginger root contains bioactive gingerols with powerful anti-inflammatory properties, and its most direct relevance to mental health runs through the gut-brain axis, where it soothes the stress-related digestive distress that both reflects and feeds anxiety. By calming gastrointestinal inflammation and supporting healthy motility, it helps quiet one of the body's loudest sources of inflammatory signaling to the brain.
Bilberry Fruit Extract
Bilberry is rich in anthocyanins, deeply pigmented flavonoids that cross the blood-brain barrier to provide localized neuroprotection and to improve cerebral circulation. These compounds combat oxidative stress in neural tissue and support the small vessels that supply the brain, contributing to the vascular side of cognitive health.
Eleuthero Root (Siberian Ginseng)
Eleuthero is a classic adaptogen traditionally used to increase energy, stamina, and resistance to both environmental and emotional stressors by helping to regulate adrenal output and the body's overall stress response. Though botanically distinct from true ginseng, it occupies a similar niche, supporting endurance and resilience during periods of sustained demand without the sharper stimulation of caffeine.
Milk Thistle
Milk thistle contains silymarin, a complex of flavonoids that supports the liver's detoxification pathways, and this matters for the brain because a liver that clears neurotoxic metabolic byproducts efficiently keeps those compounds out of circulation. By protecting hepatic function, milk thistle indirectly safeguards the cleaner internal environment that the nervous system depends on.
Grape Seed Extract
Grape seed extract is rich in proanthocyanidins, potent antioxidants that protect brain cells against oxidative damage while supporting the health and integrity of the cerebral vasculature. By strengthening blood vessels and reducing oxidative load, it reinforces the circulatory foundation on which steady cognition and mood depend.
8. Enzymes & Apicultural Products
Optimal digestion and a handful of unique biological compounds provide the quiet foundation the gut-brain axis needs to function without generating a constant background of inflammatory noise.
Papain & Bromelain
Papain and bromelain are proteolytic enzymes derived from papaya and pineapple, traditionally used to ensure the complete digestion of dietary protein into the bioavailable amino acids the brain needs to manufacture neurotransmitters, while also exerting systemic anti-inflammatory effects. Their value, in other words, begins with making the raw materials of brain chemistry actually absorbable.
More recent research reveals that bromelain in particular has direct neuroprotective effects that go well beyond digestion. It restores glutamatergic balance by upregulating the NMDA receptor NR2A subunit in the hippocampus and cortex, a subunit essential for healthy synaptic plasticity, and it significantly enhances the clearance of glutamate from the synapse. By accelerating that clearance, bromelain helps prevent the excitotoxic, pro-death signaling cascades that are triggered by environmental neurotoxins and heavy metal exposure such as arsenic, positioning a familiar digestive enzyme as a genuine protector of neural tissue.
Amylase
Amylase is the enzyme that breaks down carbohydrates, and its relevance to mood is the steadiness of blood sugar. Proper carbohydrate digestion helps prevent the sharp glucose spikes and crashes that destabilize mood and can trigger panic-like physical symptoms, supporting the even energy supply the brain requires to stay regulated.
Royal Jelly & Bee Pollen
Royal jelly and bee pollen are nutrient-dense apicultural products containing distinctive bioactive compounds, including 10-hydroxy-2-decenoic acid, flavonoids, polyphenols, and raw amino acids, that together provide highly bioavailable support for brain vitality and resilience to burnout. Their composition makes them a kind of concentrated whole-food tonic for the nervous system.
Preclinical work gives the tradition a mechanism. Supplementing with royal jelly before a stressor significantly protects against stress-induced anxiety-like behavior and cognitive decline, an effect achieved by blunting the spike in the stress hormone corticosterone and preserving hippocampal expression of brain-derived neurotrophic factor during acute stress. Integrated microbiome analyses further show that these bee-derived extracts ease intestinal inflammation and carry antibacterial, antiviral, and immune-modulating effects, adding a gut-level dimension to their neuroprotective profile.
Carrot Root, Spinach Leaf, Barley & Wheat Grass
These whole-food extracts supply a broad spectrum of naturally occurring phytonutrients, chlorophyll, folate, and antioxidants in their original biological forms, the way the body evolved to recognize and use them. Rather than isolating a single active compound, they deliver the cofactor diversity and cellular protection that round out a nutrient-dense foundation for brain health.
9. Adverse Events, Toxicology, and Pharmacokinetic Contraindications
High-potency nutraceuticals and botanicals demand the same scrutiny of drug interactions as any prescription. The belief that a natural compound is inherently safe is a dangerous fallacy that can lead to life-threatening complications, and the agents below are the ones that most often cause harm.
St. John's Wort (Hypericum perforatum)
Meta-analyses confirm that St. John's Wort is highly effective for mild-to-moderate depression, yet it is also the most notoriously interactive botanical in clinical use, and its benefits are routinely outweighed by the danger it poses in combination with other medications.
Ashwagandha and Thyrotoxicosis
Valued for its anxiolytic and adaptogenic properties, Ashwagandha nonetheless carries a severe and underreported risk of endocrine disruption that is easy to miss precisely because the herb is so widely regarded as benign.
Kava (Piper methysticum)
Kava is a genuinely potent anxiolytic, achieving its calming effect through kavalactones that act on GABA receptors and ion channels, but its use carries a heavily documented risk of severe liver injury known as kava-induced liver injury.
Emerging Synthetic and Sports Supplements
The sports and performance-enhancement industry frequently markets unverified compounds alongside ordinary vitamins, and the gap between the marketing and the evidence is wide. Selective androgen receptor modulators (SARMs) and synthetic peptides such as BPC-157 are heavily promoted for recovery and mental edge, but they are associated with severe liver toxicity, cardiovascular dysfunction, and profound endocrine disruption, which is why they sit on the World Anti-Doping Agency's list of prohibited substances.
The NAD+ precursors nicotinamide riboside and NMN show modest metabolic benefits, but their long-term safety, particularly any influence on cancer risk, still requires careful clinical study. Over-the-counter products claiming performance benefits from glutamine or nitric oxide precursors generally lack controlled human efficacy data and frequently suffer from serious quality-control failures, so the burden of proof should rest firmly on any such product before it is added to a regimen that already includes psychiatric medication.
Clinical-Grade Micronutrition Support
At Taproot Therapy Collective, we recommend utilizing highly bioavailable, broad-spectrum formulations to build the biological foundation necessary for deep psychological healing.
Use Code TAPROOT for 15% Off Hardy NutritionalsWorks Cited & Clinical References
Comprehensive scientific literature and clinical trials supporting this encyclopedia.
- Creatine Supplementation in Depression: A Review of Mechanisms, Efficacy, Clinical Outcomes, and Future Directions - PubMed
- Theoretical Potential of Hericium Erinaceus Supplementation as an Add-On to Antipsychotics in Chronic and Treatment-Resistant Schizophrenia - PMC
- Betaine Inhibits NLRP3 Inflammasome Hyperactivation and Regulates Microglial M1/M2 Phenotypic Differentiation, Thereby Attenuating Lipopolysaccharide-Induced Depression-Like Behavior - PMC
- Melatonin as a Potential Regulator of Oxidative Stress, and Neuroinflammation: Mechanisms and Implications for the Management of Brain Injury-Induced Neurodegeneration - PMC
- Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data - PMC
- Trim the fat: the role of omega-3 fatty acids in psychopharmacology - PMC
- Omega-3 fatty acids in mental disorders: from neurobiological and metabolic mechanisms to therapeutic potential - PMC
- Meta-analysis: Effects of Eicosapentaenoic Acid in Clinical Trials in Depression - PMC
- Efficacy of omega-3 PUFAs in depression: A meta-analysis - PubMed
- Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence-Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in Children and Adolescents - PMC
- Baseline Blood Levels of Omega-3 and Depression Remission: A secondary analysis of data from a placebo-controlled trial of omega-3 supplements - PMC
- Omega-3 Fatty Acids Supplementation in the Treatment of Depression: An Observational Study - PMC
- Omega-3 polyunsaturated fatty acids in depression: insights from recent clinical trials
- S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review - PMC
- S-Adenosylmethionine (SAMe) as an adjuvant therapy for patients with depression: An updated systematic review and meta-analysis - PubMed
- Efficacy and acceptability of S-adenosyl-L-methionine (SAMe) for depressed patients: a systematic review and meta-analysis of randomized controlled trials - PMC
- S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review - PubMed
- Efficacy and acceptability of S-adenosyl-L-methionine (SAMe) for depressed patients: A systematic review and meta- analysis - PubMed
- The scoop on serotonin syndrome - PMC
- Evaluating the risk of mild serotonin syndrome in primary care: a retrospective case series of patients with treatment-resistant depression - PMC
- Systematic Review of Methylenetetrahydrofolate Reductase (MTHFR) 677C>T and 1298A>C Variants and Treatment-Resistant Depression: Insights for Precision Psychiatry - PubMed
- Systematic Review of Methylenetetrahydrofolate Reductase (MTHFR) 677C>T and 1298A>C Variants and Treatment-Resistant Depression: Insights for Precision Psychiatry - Karger Publishers
- Methylenetetrahydrofolate Reductase Screening in Treatment-Resistant Depression - PMC
- Assessing Effects of l-Methylfolate in Depression Management: Results of a Real-World Patient Experience Trial - PMC
- L-Methylfolate as a Monotherapy for Treatment-Resistant Depression: A Case Study - PMC
- Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders - PubMed
- A Randomized, Double-Blind Placebo-Controlled Trial of Oral Creatine Monohydrate Augmentation for Enhanced Response to a Selective Serotonin Reuptake Inhibitor in Women With Major Depressive Disorder - PMC
- A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo - PMC
- Creatine Supplementation in Depression: A Review of Mechanisms, Efficacy, Clinical Outcomes, and Future Directions - PMC
- The Effect of Creatine Monohydrate on Mental Disorders: A Systematic Review of Randomized Controlled Trials - PMC
- The Effect of Creatine Monohydrate on Mental Disorders: A Systematic Review of Randomized Controlled Trials - PubMed
- Antidepressant effects of open label treatment with Coenzyme Q10 in Geriatric Bipolar Depression - PMC
- Evaluating the Effect of Coenzyme Q10 Augmentation on Treatment of Bipolar Depression: A Double-Blind Controlled Clinical Trial - PubMed
- Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression
- Effects of Coenzyme Q10 Supplementation on Depressive Symptoms and Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PubMed
- Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action - PubMed
- Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials - PubMed
- Effectivity of Saffron Extract (Saffr'Activ) on Treatment for Children and Adolescents with Attention Deficit/Hyperactivity Disorder (ADHD): A Clinical Effectivity Study - PMC
- Effect of saffron on depression, anxiety and mood disorder: a GRADE assessed systematic review and meta-analysis of 34 randomized controlled trials - PubMed
- The Efficacy of Saffron in the Treatment of Mild to Moderate Depression: A Meta-analysis
- Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis - PubMed
- A Comparison of Methylphenidate (MPH) and Combined Methylphenidate with Crocus sativus (Saffron) in the Treatment of Children and Adolescents with ADHD: A Randomized, Double-Blind, Parallel-Group, Clinical Trial - Brieflands
- The Effects of Crocus sativus (Saffron) on ADHD: A Systematic Review - PubMed
- Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice - PubMed
- Palmitoylethanolamide: A Multifunctional Molecule for Neuroprotection, Chronic Pain, and Immune Modulation - PMC
- Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial - PubMed
- Micronized/ultramicronized palmitoylethanolamide improves depression and fatigue in coronavirus disease 2019 (COVID-19) survivors - PMC
- The effects of formulated palmitoylethanolamide supplementation on indicators of stress and heart rate variability in female university students: a randomised cross-over trial - PMC
- Betaine improves METH-induced depressive-like behavior and cognitive impairment by alleviating neuroinflammation via NLRP3 inflammasome inhibition - PubMed
- Prophylactic Effects of Betaine on Depression and Anxiety Behaviors in Mice with Dextran Sulfate Sodium-Induced Colitis - PubMed
- Betaine: A Promising Natural Product for Neurological and Psychiatric Diseases - PubMed
- Double-Blind, Controlled, Crossover Trial of Inositol Versus Fluvoxamine for the Treatment of Panic Disorder - Ovid
- Potential Anxiolytic Effects of Selected Inositol Stereoisomers: A Narrative Review - MDPI
- Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder - PubMed
- Controlled trials of inositol in psychiatry - PubMed
- Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder
- Inositol treatment of obsessive-compulsive disorder - PubMed
- A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women - PMC - NIH
- Inositols in PCOS - PMC - NIH
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome - Taylor & Francis
- A Magtein, Magnesium L-Threonate, Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults - PMC
- Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial - PMC
- The effects of magnesium L-threonate (Magtein) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial - PMC
- Chronic dietary magnesium-L-threonate speeds extinction and reduces spontaneous recovery of a conditioned taste aversion - PMC
- Unlocking the Power of Magnesium: A Systematic Review and Meta-Analysis Regarding Its Role in Oxidative Stress and Inflammation - PMC
- Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial - PubMed
- Chronic Organic Magnesium Supplementation Enhances Tissue-Specific Bioavailability and Functional Capacity in Rats: A Focus on Brain, Muscle, and Vascular Health - PMC
- Timeline (Bioavailability) of Magnesium Compounds in Hours: Which Magnesium Compound Works Best? - PubMed
- Magnesium bioavailability from magnesium citrate and magnesium oxide - PubMed - NIH
- Intestinal Absorption and Factors Influencing Bioavailability of Magnesium: An Update - PMC
- Predicting and Testing Bioavailability of Magnesium Supplements - PMC - NIH
- Apigenin: a natural molecule at the intersection of sleep and aging - PMC
- Enhancement of pentobarbital-induced sleep by apigenin through chloride ion channel activation - PubMed
- Apigenin: a natural molecule at the intersection of sleep and aging - PubMed
- Synergistic sleep-promoting effects of magnesium and apigenin in normal and insomnia mouse models - Food & Function
- Rhodiola rosea L.: an herb with anti-stress, anti-aging, and immunostimulating properties for cancer chemoprevention - PMC
- The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions: Encouraging Clinical Evidence - PMC
- Rhodiola rosea for physical and mental fatigue: a systematic review - PMC
- Common herbs for stress: The science and strategy of a botanical medicine approach to self-care - PMC
- The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions - PubMed
- Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea - PMC
- Standardized Holy Basil Extract (Holixer, 250 mg/day) Improves Stress and Sleep Outcomes and Reduces Cortisol Reactivity in Stressed Adults: Evidence from an 8-Week RCT - Natural Health Research
- Ocimum tenuiflorum extract (HOLIXER): Possible effects on hypothalamic-pituitary-adrenal (HPA) axis in modulating stress - PMC
- A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract (Holixer) on stress, mood, and sleep in adults experiencing stress - PubMed
- Passiflora incarnata in Neuropsychiatric Disorders: A Systematic Review - PMC
- The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta-analysis - PubMed
- Clinical Efficacy and Tolerability of Lemon Balm (Melissa officinalis L.) in Psychological Well-Being: A Review - PMC
- Passiflora incarnata in Neuropsychiatric Disorders - PubMed
- Passiflora for anxiety disorder - PubMed
- Melatonin: Novel Insights in the Treatment of Neurodegenerative Diseases - PubMed
- Neurological Enhancement Effects of Melatonin against Brain Injury-Induced Oxidative Stress, Neuroinflammation, and Neurodegeneration via AMPK/CREB Signaling - PMC
- Melatonin Reduces Neuroinflammation and Improves Axonal Hypomyelination by Modulating M1/M2 Microglia Polarization via JAK2-STAT3-Telomerase Pathway in Postnatal Rats Exposed to Lipopolysaccharide - PubMed
- Psychobiotics: Are they the future intervention for managing depression and anxiety? A literature review - PMC
- Probiotics' Effects in the Treatment of Anxiety and Depression: A Comprehensive Review of 2014-2023 Clinical Trials - PMC
- Psychobiotics in Depression: Sources, Metabolites, and Treatment: A Systematic Review
- Overall Rebalancing of Gut Microbiota Is Key to Autism Intervention - PMC - NIH
- Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders - PMC
- Effects of a Psychobiotic Supplement on Serum Brain-derived Neurotrophic Factor Levels in Depressive Patients: A Post Hoc Analysis of a Randomized Clinical Trial - Journal of Neurogastroenterology and Motility
- A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression - PMC
- Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects - PubMed
- How probiotics can reduce anxiety and depression - Life Extension
- Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers - Taylor & Francis
- Effect of Probiotics on the Symptomatology of Autism Spectrum Disorder and/or Attention Deficit/Hyperactivity Disorder in Children and Adolescents: Pilot Study - PMC
- Effects of Lactobacillus plantarum PS128 on Children with Autism Spectrum Disorder in Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial - PMC
- Randomized Controlled Trial of Probiotic PS128 in Children with Tourette Syndrome - PMC
- Autism Spectrum Disorder: From Experimental Models to Probiotic Application with a Special Focus on Lactiplantibacillus plantarum - PMC
- The effect of phosphatidylserine on behavioral problems in children with attention deficit hyperactivity disorder - PMC
- The cognitive effects of supplementation with sunflower phosphatidyl serine in healthy children aged 8 to 12 years: a randomized controlled trial - PMC
- The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial - PubMed
- The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension - PubMed
- A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers - PubMed
- Comparison of the effects of choline alphoscerate and citicoline in patients with dementia disorders: a systematic review and meta-analysis - PMC
- Comparison of the effects of choline alphoscerate and citicoline in patients with dementia disorders: a systematic review and meta-analysis - PubMed
- Comparison of the effects of choline alphoscerate and citicoline in patients with dementia disorders: a systematic review and meta-analysis - Frontiers
- The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives - PMC
- Application of Citicoline in Neurological Disorders: A Systematic Review - PMC
- Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents - PMC
- Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease - PMC
- The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials - PubMed
- The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials - NCBI
- Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis - PubMed
- The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study - PMC
- Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study - PMC
- Lion's Mane - LiverTox - NCBI Bookshelf
- The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults - PubMed
- Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers? - PMC
- L-theanine and caffeine improve task switching but not intersensory attention or subjective alertness - PubMed
- The combination of L-theanine and caffeine improves cognitive performance and increases subjective alertness - PubMed
- High-dose L-theanine-caffeine combination improves neurobehavioural and neurophysiological measures of selective attention in acutely sleep-deprived young adults - PubMed
- The combined effects of L-theanine and caffeine on cognitive performance and mood
- High-dose L-theanine-caffeine combination improves neurobehavioural and neurophysiological measures of selective attention in acutely sleep-deprived young adults - PMC
- Use of Non-Pharmacological Supplementations in Children and Adolescents with Attention Deficit/Hyperactivity Disorder: A Critical Review - PMC
- Oral Supplementation with L-Carnosine Attenuates Social Recognition Deficits in CD157KO Mice via Oxytocin Release - PMC
- Effect of L-Carnosine in children with autism spectrum disorders: a systematic review and meta-analysis of randomised controlled trials - PubMed
- Evaluating the impact of essential amino acid-rich nutrition intervention on children with autism spectrum disorder: A randomized trial protocol - PMC
- Effect of L-Carnosine as adjunctive therapy in the management of children with autism spectrum disorder: a randomized controlled study - PubMed
- The Effects of Carnosine on Cognitive Function and Mental Health: A Systematic Review - PMC
- Zinc in the Brain: Friend or Foe? - PMC - NIH
- The Effect of Zinc Supplementation on Circulating Levels of Brain-Derived Neurotrophic Factor (BDNF): A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PMC
- Dietary Zn: Recent Advances in Studies on Its Bioaccessibility and Bioavailability - PMC
- Comparison of the Potential Relative Bioaccessibility of Zinc Supplements: In Vitro Studies
- Comparative Absorption and Bioavailability of Various Chemical Forms of Zinc in Humans: A Narrative Review - PMC
- Iron Deficiency Across Neurodevelopmental Disorders: Comparative Insights from ADHD and Autism Spectrum Disorder - PMC
- Impact of Serum Ferritin on the Pathophysiology of Attention-Deficit/Hyperactivity Disorder: What Is the Evidence? - PMC
- Effect of supplementation with ferrous sulfate or iron bis-glycinate chelate on ferritin concentration in Mexican schoolchildren: a randomized controlled trial - PMC
- Effect of supplementation with ferrous sulfate or iron bis-glycinate chelate on ferritin concentration in Mexican schoolchildren: a randomized controlled trial - PubMed
- Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial - PubMed
- Trace Minerals and Anxiety: A Review of Zinc, Copper, Iron, and Selenium - MDPI
- The Relationship Between Trace Elements and Depression - PMC
- Autism Spectrum Disorder and Long-Term Survival in Attenuated Molybdenum Cofactor Deficiency Type A: A Case Report - PMC
- Duration effects of micronutrients in children with ADHD: Randomised controlled trial vs. Open-Label extension - PMC
- Plant-Derived Nutraceuticals in Mental Health and Brain Function: Mechanisms of Action and Therapeutic Potential - PMC
- Taurine supplementation at the crossroads of metabolism, inflammation and aging: mechanistic and nutritional perspectives - RSC Publishing
- Bromelain Restores Glutamatergic Homeostasis via Regulation of the NMDAR NR2A Subunit - PMC
- Health Effects of Bee Products: A Comprehensive Review - PMC - NIH
- Royal Jelly Mitigates Cognitive Decline and Anxiety in Female Mice: A Promising Natural Neuroprotective Solution for Alzheimer's Disease - MDPI
- Pre-treatment with royal jelly, environmental enrichment, and their combination alleviates stress-induced behavioral and cognitive deficits - PMC
- Health Benefits of a Standardized Ginkgo biloba Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance - PMC
- A Case Series on the Combined Use of Zinc L-Carnosine and Nd:YAG Photobiomodulation for Radiation-Induced Oral Mucositis - PMC
- Pre-clinical Evaluation of Shilajit in Cancer: A Systematic Review - PMC
- The Efficacy of Spirulina on Cognitive Function, Psychological and Clinical Indicators in Men Patients Under Methadone Therapy: A Randomized Trial - PMC
- Herb-Drug Interactions with St John's Wort (Hypericum perforatum): an Update on Clinical Observations - PMC
- Advantages and Disadvantages of Using St. John's Wort as a Treatment for Depression
- St. John's Wort - StatPearls - NCBI Bookshelf
- Clinical relevance of St. John's wort drug interactions revisited - PMC
- The Effects of St. John's Wort and its Interactions with SSRI's - PMC
- Linezolid and Serotonin Syndrome - PMC - NIH
- Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report - PMC
- Selective Serotonin Reuptake Inhibitors and Risk of Serotonin Syndrome as Consequence of Drug-Drug Interactions: Analysis of the FDA Adverse Event Reporting System - PMC
- Ashwagandha as a Unique Cause of Thyrotoxicosis Presenting With Supraventricular Tachycardia - PMC
- Painless Thyroiditis by Withania somnifera (Ashwagandha) - PMC - NIH
- Understanding Synergy: Why You Shouldn't Mix Synthroid and Ashwagandha - Ubie Doctor's Note
- Potential Adverse Effects of Ashwagandha: A Critical Review of Preclinical and Clinical Evidence - PubMed
- Ashwagandha: Usefulness and Safety - National Center for Complementary and Integrative Health (NCCIH)
- Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited - PMC
- Biological Activity, Hepatotoxicity, and Structure-Activity Relationship of Kavalactones and Flavokavins, the Two Main Bioactive Components in Kava (Piper methysticum) - PMC
- A re-evaluation of kava (Piper methysticum) - PMC - NIH
- Kava Herb-Induced Liver Injury as Verified by the Updated RUCAM - PMC
- Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence - PubMed
- An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava - PMC
- Potential for interaction of kava and St. John's wort with drugs - PubMed
- Controversial supplements and emerging doping alternatives in sports: A critical review of evidence, safety, and detection challenges - ResearchGate
- Emerging Supplements in Sports: Sports Health: A Multidisciplinary Approach - Ovid
- Current state of nutritional psychiatry: A scoping review of randomized controlled trials - PMC
- Nutritional Psychiatry: A Novel Approach to the Treatment of Mental Health Disorders - PMC
- Mindful eating as the next therapeutic frontier in nutritional psychiatry - PMC - NIH
Medical, Scientific & Scope of Practice Disclaimer
Taproot Therapy Collective operates as a private psychotherapy clinic in Birmingham, Alabama. We are not medical doctors, and we do not prescribe or manage psychiatric medication. The information provided in this clinical encyclopedia regarding nutritional psychology, neurobiology, and micronutrition reflects current scientific research and is strictly for educational purposes. It does not constitute medical advice or establish a therapist-client relationship.
Because clinical-grade micronutrition balances and optimizes natural neurological functions, other supplements, psychiatric medications, and substances may need to be appropriately reduced or discontinued by your doctor to prevent over-medication. Always consult with your prescribing physician or a qualified healthcare professional before starting any supplement regimen or adjusting your current medication. If you are experiencing a mental health emergency, severe psychological distress, or suicidal ideation, please dial 988 or seek immediate medical attention at an emergency room.
